Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
EJNMMI Research|January 9, 2025
Hepatobiliary scintigraphy and liver function changes in patients with hepatocellular carcinoma treated with <sup>166</sup>Ho-radioembolization : HBS in HCC treated with holmium-166Margot T M Reinders, Maarten J L Smits, Karel van Erpecum, et al.Carcinogenesis|October 17, 2018
Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinomaPengyu Liu, Wanlu Cao, Buyun Ma, et al.Oncoimmunology|July 9, 2015
Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumorsAlexander Pedroza-Gonzalez, Guoying Zhou, Ernesto Vargas-Mendez, et al.Gastroenterology|June 27, 2017
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular CarcinomasGuoying Zhou, Dave Sprengers, Patrick P C Boor, et al.Transplantation|February 13, 2019
Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in PatientsKan Chen, Jiexin Sheng, Buyun Ma, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
Safety and Efficacy of <sup>166</sup>Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary StudyMargot T M Reinders, Karel J van Erpecum, Maarten L J Smits, et al.Journal of Hepatology|June 24, 2015
Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the NetherlandsSuzanne van Meer, Robert A de Man, Minneke J Coenraad, et al.Journal of Experimental & Clinical Cancer Research : CR|May 15, 2025
Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and BloodSiyu Fu, Ruben G Boers, Joachim B Boers, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2021
Activated CD4<sup>+</sup> T Cells and Highly Differentiated Alloreactive CD4<sup>+</sup> T Cells Distinguish Operationally Tolerant Liver Transplantation RecipientsAafke A Duizendstra, Robert J de Knegt, Shanta Mancham, et al.BMJ Open|October 18, 2018
Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility studyMerel S Koedijk, Ben J M Heijmen, Bas Groot Koerkamp, et al.Pageof 9